STAT

Opinion: Compounding pharmacies need stricter federal oversight

Compounding pharmacies are not bartenders mixing a gin and tonic. They produce essentially new drugs. The regulatory loophole that allows compounders to avoid necessary federal scrutiny must be closed.

Millions of Americans use compounded drugs created by a pharmacist or physician who combines, mixes, or changes a drug’s ingredients to meet individuals’ needs. They trust the 7,500 or so compounding pharmacies that do this work.

That trust is sometimes misplaced. In 2012, for example, contaminated steroid painkillers mass-produced by the now-defunct New England Compounding Center in Framingham, Mass., and sickened more than 750 others . Barry Cadden, the center’s president, and Glenn Chin, a pharmacist,

You're reading a preview, sign up to read more.

More from STAT

STAT7 min readTech
One Health Care Startup At A Time, This Venture Capitalist Wants To Harness The Investing Power Of Women
“If women want specific companies in the world that address their needs, the only way to do that is for women to become the investors."
STAT4 min readSociety
Opinion: Bringing Transparency To The Notion Of Price Transparency
Transparency is not just a goal. It's also an ethic. Organizations involved in price transparency initiatives should be transparent in the ways appropriate to them.
STAT1 min read
Listen: The Serious Side Of Spit Kits, How BiTEs Leave A Mark, & Sarepta’s Sluggish Study
Is anything too weighty to be explained over the internet? Can a new spin on old technology outfox CAR-T? And does that controversial drug even work? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. Fi